for Journals by Title or ISSN
for Articles by Keywords
help

Publisher: Elsevier   (Total: 3163 journals)

 A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

        1 2 3 4 5 6 7 8 | Last   [Sort by number of followers]   [Restore default list]

Showing 1 - 200 of 3163 Journals sorted alphabetically
A Practical Logic of Cognitive Systems     Full-text available via subscription   (Followers: 9)
AASRI Procedia     Open Access   (Followers: 14)
Academic Pediatrics     Hybrid Journal   (Followers: 30, SJR: 1.655, CiteScore: 2)
Academic Radiology     Hybrid Journal   (Followers: 22, SJR: 1.015, CiteScore: 2)
Accident Analysis & Prevention     Partially Free   (Followers: 88, SJR: 1.462, CiteScore: 3)
Accounting Forum     Hybrid Journal   (Followers: 25, SJR: 0.932, CiteScore: 2)
Accounting, Organizations and Society     Hybrid Journal   (Followers: 35, SJR: 1.771, CiteScore: 3)
Achievements in the Life Sciences     Open Access   (Followers: 5)
Acta Anaesthesiologica Taiwanica     Open Access   (Followers: 7)
Acta Astronautica     Hybrid Journal   (Followers: 394, SJR: 0.758, CiteScore: 2)
Acta Automatica Sinica     Full-text available via subscription   (Followers: 2)
Acta Biomaterialia     Hybrid Journal   (Followers: 27, SJR: 1.967, CiteScore: 7)
Acta Colombiana de Cuidado Intensivo     Full-text available via subscription   (Followers: 2)
Acta de Investigación Psicológica     Open Access   (Followers: 3)
Acta Ecologica Sinica     Open Access   (Followers: 8, SJR: 0.18, CiteScore: 1)
Acta Haematologica Polonica     Free   (Followers: 1, SJR: 0.128, CiteScore: 0)
Acta Histochemica     Hybrid Journal   (Followers: 3, SJR: 0.661, CiteScore: 2)
Acta Materialia     Hybrid Journal   (Followers: 244, SJR: 3.263, CiteScore: 6)
Acta Mathematica Scientia     Full-text available via subscription   (Followers: 5, SJR: 0.504, CiteScore: 1)
Acta Mechanica Solida Sinica     Full-text available via subscription   (Followers: 9, SJR: 0.542, CiteScore: 1)
Acta Oecologica     Hybrid Journal   (Followers: 10, SJR: 0.834, CiteScore: 2)
Acta Otorrinolaringologica (English Edition)     Full-text available via subscription  
Acta Otorrinolaringológica Española     Full-text available via subscription   (Followers: 2, SJR: 0.307, CiteScore: 0)
Acta Pharmaceutica Sinica B     Open Access   (Followers: 1, SJR: 1.793, CiteScore: 6)
Acta Poética     Open Access   (Followers: 4, SJR: 0.101, CiteScore: 0)
Acta Psychologica     Hybrid Journal   (Followers: 27, SJR: 1.331, CiteScore: 2)
Acta Sociológica     Open Access  
Acta Tropica     Hybrid Journal   (Followers: 6, SJR: 1.052, CiteScore: 2)
Acta Urológica Portuguesa     Open Access  
Actas Dermo-Sifiliograficas     Full-text available via subscription   (Followers: 3, SJR: 0.374, CiteScore: 1)
Actas Dermo-Sifiliográficas (English Edition)     Full-text available via subscription   (Followers: 2)
Actas Urológicas Españolas     Full-text available via subscription   (Followers: 3, SJR: 0.344, CiteScore: 1)
Actas Urológicas Españolas (English Edition)     Full-text available via subscription   (Followers: 1)
Actualites Pharmaceutiques     Full-text available via subscription   (Followers: 6, SJR: 0.19, CiteScore: 0)
Actualites Pharmaceutiques Hospitalieres     Full-text available via subscription   (Followers: 3)
Acupuncture and Related Therapies     Hybrid Journal   (Followers: 6)
Acute Pain     Full-text available via subscription   (Followers: 15, SJR: 2.671, CiteScore: 5)
Ad Hoc Networks     Hybrid Journal   (Followers: 11, SJR: 0.53, CiteScore: 4)
Addictive Behaviors     Hybrid Journal   (Followers: 16, SJR: 1.29, CiteScore: 3)
Addictive Behaviors Reports     Open Access   (Followers: 8, SJR: 0.755, CiteScore: 2)
Additive Manufacturing     Hybrid Journal   (Followers: 9, SJR: 2.611, CiteScore: 8)
Additives for Polymers     Full-text available via subscription   (Followers: 22)
Advanced Cement Based Materials     Full-text available via subscription   (Followers: 3, SJR: 0.732, CiteScore: 3)
Advanced Drug Delivery Reviews     Hybrid Journal   (Followers: 134, SJR: 4.09, CiteScore: 13)
Advanced Engineering Informatics     Hybrid Journal   (Followers: 11, SJR: 1.167, CiteScore: 4)
Advanced Powder Technology     Hybrid Journal   (Followers: 16, SJR: 0.694, CiteScore: 3)
Advances in Accounting     Hybrid Journal   (Followers: 8, SJR: 0.277, CiteScore: 1)
Advances in Agronomy     Full-text available via subscription   (Followers: 12, SJR: 2.384, CiteScore: 5)
Advances in Anesthesia     Full-text available via subscription   (Followers: 28, SJR: 0.126, CiteScore: 0)
Advances in Antiviral Drug Design     Full-text available via subscription   (Followers: 2)
Advances in Applied Mathematics     Full-text available via subscription   (Followers: 10, SJR: 0.992, CiteScore: 1)
Advances in Applied Mechanics     Full-text available via subscription   (Followers: 10, SJR: 1.551, CiteScore: 4)
Advances in Applied Microbiology     Full-text available via subscription   (Followers: 22, SJR: 2.089, CiteScore: 5)
Advances In Atomic, Molecular, and Optical Physics     Full-text available via subscription   (Followers: 14, SJR: 0.572, CiteScore: 2)
Advances in Biological Regulation     Hybrid Journal   (Followers: 4, SJR: 2.61, CiteScore: 7)
Advances in Botanical Research     Full-text available via subscription   (Followers: 2, SJR: 0.686, CiteScore: 2)
Advances in Cancer Research     Full-text available via subscription   (Followers: 29, SJR: 3.043, CiteScore: 6)
Advances in Carbohydrate Chemistry and Biochemistry     Full-text available via subscription   (Followers: 7, SJR: 1.453, CiteScore: 2)
Advances in Catalysis     Full-text available via subscription   (Followers: 5, SJR: 1.992, CiteScore: 5)
Advances in Cell Aging and Gerontology     Full-text available via subscription   (Followers: 3)
Advances in Cellular and Molecular Biology of Membranes and Organelles     Full-text available via subscription   (Followers: 12)
Advances in Chemical Engineering     Full-text available via subscription   (Followers: 27, SJR: 0.156, CiteScore: 1)
Advances in Child Development and Behavior     Full-text available via subscription   (Followers: 10, SJR: 0.713, CiteScore: 1)
Advances in Chronic Kidney Disease     Full-text available via subscription   (Followers: 10, SJR: 1.316, CiteScore: 2)
Advances in Clinical Chemistry     Full-text available via subscription   (Followers: 28, SJR: 1.562, CiteScore: 3)
Advances in Colloid and Interface Science     Full-text available via subscription   (Followers: 19, SJR: 1.977, CiteScore: 8)
Advances in Computers     Full-text available via subscription   (Followers: 14, SJR: 0.205, CiteScore: 1)
Advances in Dermatology     Full-text available via subscription   (Followers: 15)
Advances in Developmental Biology     Full-text available via subscription   (Followers: 11)
Advances in Digestive Medicine     Open Access   (Followers: 8)
Advances in DNA Sequence-Specific Agents     Full-text available via subscription   (Followers: 5)
Advances in Drug Research     Full-text available via subscription   (Followers: 23)
Advances in Ecological Research     Full-text available via subscription   (Followers: 42, SJR: 2.524, CiteScore: 4)
Advances in Engineering Software     Hybrid Journal   (Followers: 27, SJR: 1.159, CiteScore: 4)
Advances in Experimental Biology     Full-text available via subscription   (Followers: 7)
Advances in Experimental Social Psychology     Full-text available via subscription   (Followers: 43, SJR: 5.39, CiteScore: 8)
Advances in Exploration Geophysics     Full-text available via subscription   (Followers: 1)
Advances in Fluorine Science     Full-text available via subscription   (Followers: 9)
Advances in Food and Nutrition Research     Full-text available via subscription   (Followers: 53, SJR: 0.591, CiteScore: 2)
Advances in Fuel Cells     Full-text available via subscription   (Followers: 17)
Advances in Genetics     Full-text available via subscription   (Followers: 15, SJR: 1.354, CiteScore: 4)
Advances in Genome Biology     Full-text available via subscription   (Followers: 8, SJR: 12.74, CiteScore: 13)
Advances in Geophysics     Full-text available via subscription   (Followers: 6, SJR: 1.193, CiteScore: 3)
Advances in Heat Transfer     Full-text available via subscription   (Followers: 21, SJR: 0.368, CiteScore: 1)
Advances in Heterocyclic Chemistry     Full-text available via subscription   (Followers: 11, SJR: 0.749, CiteScore: 3)
Advances in Human Factors/Ergonomics     Full-text available via subscription   (Followers: 22)
Advances in Imaging and Electron Physics     Full-text available via subscription   (Followers: 2, SJR: 0.193, CiteScore: 0)
Advances in Immunology     Full-text available via subscription   (Followers: 37, SJR: 4.433, CiteScore: 6)
Advances in Inorganic Chemistry     Full-text available via subscription   (Followers: 8, SJR: 1.163, CiteScore: 2)
Advances in Insect Physiology     Full-text available via subscription   (Followers: 2, SJR: 1.938, CiteScore: 3)
Advances in Integrative Medicine     Hybrid Journal   (Followers: 6, SJR: 0.176, CiteScore: 0)
Advances in Intl. Accounting     Full-text available via subscription   (Followers: 3)
Advances in Life Course Research     Hybrid Journal   (Followers: 8, SJR: 0.682, CiteScore: 2)
Advances in Lipobiology     Full-text available via subscription   (Followers: 1)
Advances in Magnetic and Optical Resonance     Full-text available via subscription   (Followers: 9)
Advances in Marine Biology     Full-text available via subscription   (Followers: 14, SJR: 0.88, CiteScore: 2)
Advances in Mathematics     Full-text available via subscription   (Followers: 11, SJR: 3.027, CiteScore: 2)
Advances in Medical Sciences     Hybrid Journal   (Followers: 6, SJR: 0.694, CiteScore: 2)
Advances in Medicinal Chemistry     Full-text available via subscription   (Followers: 5)
Advances in Microbial Physiology     Full-text available via subscription   (Followers: 4, SJR: 1.158, CiteScore: 3)
Advances in Molecular and Cell Biology     Full-text available via subscription   (Followers: 21)
Advances in Molecular and Cellular Endocrinology     Full-text available via subscription   (Followers: 8)
Advances in Molecular Toxicology     Full-text available via subscription   (Followers: 7, SJR: 0.182, CiteScore: 0)
Advances in Nanoporous Materials     Full-text available via subscription   (Followers: 3)
Advances in Oncobiology     Full-text available via subscription   (Followers: 1)
Advances in Organ Biology     Full-text available via subscription   (Followers: 1)
Advances in Organometallic Chemistry     Full-text available via subscription   (Followers: 16, SJR: 1.875, CiteScore: 4)
Advances in Parallel Computing     Full-text available via subscription   (Followers: 6, SJR: 0.174, CiteScore: 0)
Advances in Parasitology     Full-text available via subscription   (Followers: 5, SJR: 1.579, CiteScore: 4)
Advances in Pediatrics     Full-text available via subscription   (Followers: 24, SJR: 0.461, CiteScore: 1)
Advances in Pharmaceutical Sciences     Full-text available via subscription   (Followers: 10)
Advances in Pharmacology     Full-text available via subscription   (Followers: 16, SJR: 1.536, CiteScore: 3)
Advances in Physical Organic Chemistry     Full-text available via subscription   (Followers: 8, SJR: 0.574, CiteScore: 1)
Advances in Phytomedicine     Full-text available via subscription  
Advances in Planar Lipid Bilayers and Liposomes     Full-text available via subscription   (Followers: 3, SJR: 0.109, CiteScore: 1)
Advances in Plant Biochemistry and Molecular Biology     Full-text available via subscription   (Followers: 8)
Advances in Plant Pathology     Full-text available via subscription   (Followers: 5)
Advances in Porous Media     Full-text available via subscription   (Followers: 5)
Advances in Protein Chemistry     Full-text available via subscription   (Followers: 18)
Advances in Protein Chemistry and Structural Biology     Full-text available via subscription   (Followers: 19, SJR: 0.791, CiteScore: 2)
Advances in Psychology     Full-text available via subscription   (Followers: 59)
Advances in Quantum Chemistry     Full-text available via subscription   (Followers: 6, SJR: 0.371, CiteScore: 1)
Advances in Radiation Oncology     Open Access   (SJR: 0.263, CiteScore: 1)
Advances in Small Animal Medicine and Surgery     Hybrid Journal   (Followers: 3, SJR: 0.101, CiteScore: 0)
Advances in Space Biology and Medicine     Full-text available via subscription   (Followers: 5)
Advances in Space Research     Full-text available via subscription   (Followers: 385, SJR: 0.569, CiteScore: 2)
Advances in Structural Biology     Full-text available via subscription   (Followers: 5)
Advances in Surgery     Full-text available via subscription   (Followers: 10, SJR: 0.555, CiteScore: 2)
Advances in the Study of Behavior     Full-text available via subscription   (Followers: 29, SJR: 2.208, CiteScore: 4)
Advances in Veterinary Medicine     Full-text available via subscription   (Followers: 17)
Advances in Veterinary Science and Comparative Medicine     Full-text available via subscription   (Followers: 13)
Advances in Virus Research     Full-text available via subscription   (Followers: 5, SJR: 2.262, CiteScore: 5)
Advances in Water Resources     Hybrid Journal   (Followers: 46, SJR: 1.551, CiteScore: 3)
Aeolian Research     Hybrid Journal   (Followers: 6, SJR: 1.117, CiteScore: 3)
Aerospace Science and Technology     Hybrid Journal   (Followers: 335, SJR: 0.796, CiteScore: 3)
AEU - Intl. J. of Electronics and Communications     Hybrid Journal   (Followers: 8, SJR: 0.42, CiteScore: 2)
African J. of Emergency Medicine     Open Access   (Followers: 6, SJR: 0.296, CiteScore: 0)
Ageing Research Reviews     Hybrid Journal   (Followers: 10, SJR: 3.671, CiteScore: 9)
Aggression and Violent Behavior     Hybrid Journal   (Followers: 436, SJR: 1.238, CiteScore: 3)
Agri Gene     Hybrid Journal   (SJR: 0.13, CiteScore: 0)
Agricultural and Forest Meteorology     Hybrid Journal   (Followers: 15, SJR: 1.818, CiteScore: 5)
Agricultural Systems     Hybrid Journal   (Followers: 31, SJR: 1.156, CiteScore: 4)
Agricultural Water Management     Hybrid Journal   (Followers: 43, SJR: 1.272, CiteScore: 3)
Agriculture and Agricultural Science Procedia     Open Access   (Followers: 1)
Agriculture and Natural Resources     Open Access   (Followers: 2)
Agriculture, Ecosystems & Environment     Hybrid Journal   (Followers: 56, SJR: 1.747, CiteScore: 4)
Ain Shams Engineering J.     Open Access   (Followers: 5, SJR: 0.589, CiteScore: 3)
Air Medical J.     Hybrid Journal   (Followers: 6, SJR: 0.26, CiteScore: 0)
AKCE Intl. J. of Graphs and Combinatorics     Open Access   (SJR: 0.19, CiteScore: 0)
Alcohol     Hybrid Journal   (Followers: 11, SJR: 1.153, CiteScore: 3)
Alcoholism and Drug Addiction     Open Access   (Followers: 9)
Alergologia Polska : Polish J. of Allergology     Full-text available via subscription   (Followers: 1)
Alexandria Engineering J.     Open Access   (Followers: 1, SJR: 0.604, CiteScore: 3)
Alexandria J. of Medicine     Open Access   (Followers: 1, SJR: 0.191, CiteScore: 1)
Algal Research     Partially Free   (Followers: 10, SJR: 1.142, CiteScore: 4)
Alkaloids: Chemical and Biological Perspectives     Full-text available via subscription   (Followers: 2)
Allergologia et Immunopathologia     Full-text available via subscription   (Followers: 1, SJR: 0.504, CiteScore: 1)
Allergology Intl.     Open Access   (Followers: 5, SJR: 1.148, CiteScore: 2)
Alpha Omegan     Full-text available via subscription   (SJR: 3.521, CiteScore: 6)
ALTER - European J. of Disability Research / Revue Européenne de Recherche sur le Handicap     Full-text available via subscription   (Followers: 9, SJR: 0.201, CiteScore: 1)
Alzheimer's & Dementia     Hybrid Journal   (Followers: 50, SJR: 4.66, CiteScore: 10)
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring     Open Access   (Followers: 4, SJR: 1.796, CiteScore: 4)
Alzheimer's & Dementia: Translational Research & Clinical Interventions     Open Access   (Followers: 4, SJR: 1.108, CiteScore: 3)
Ambulatory Pediatrics     Hybrid Journal   (Followers: 6)
American Heart J.     Hybrid Journal   (Followers: 50, SJR: 3.267, CiteScore: 4)
American J. of Cardiology     Hybrid Journal   (Followers: 51, SJR: 1.93, CiteScore: 3)
American J. of Emergency Medicine     Hybrid Journal   (Followers: 44, SJR: 0.604, CiteScore: 1)
American J. of Geriatric Pharmacotherapy     Full-text available via subscription   (Followers: 10)
American J. of Geriatric Psychiatry     Hybrid Journal   (Followers: 14, SJR: 1.524, CiteScore: 3)
American J. of Human Genetics     Hybrid Journal   (Followers: 32, SJR: 7.45, CiteScore: 8)
American J. of Infection Control     Hybrid Journal   (Followers: 26, SJR: 1.062, CiteScore: 2)
American J. of Kidney Diseases     Hybrid Journal   (Followers: 34, SJR: 2.973, CiteScore: 4)
American J. of Medicine     Hybrid Journal   (Followers: 43)
American J. of Medicine Supplements     Full-text available via subscription   (Followers: 3, SJR: 1.967, CiteScore: 2)
American J. of Obstetrics and Gynecology     Hybrid Journal   (Followers: 203, SJR: 2.7, CiteScore: 4)
American J. of Ophthalmology     Hybrid Journal   (Followers: 62, SJR: 3.184, CiteScore: 4)
American J. of Ophthalmology Case Reports     Open Access   (Followers: 6, SJR: 0.265, CiteScore: 0)
American J. of Orthodontics and Dentofacial Orthopedics     Full-text available via subscription   (Followers: 6, SJR: 1.289, CiteScore: 1)
American J. of Otolaryngology     Hybrid Journal   (Followers: 25, SJR: 0.59, CiteScore: 1)
American J. of Pathology     Hybrid Journal   (Followers: 27, SJR: 2.139, CiteScore: 4)
American J. of Preventive Medicine     Hybrid Journal   (Followers: 27, SJR: 2.164, CiteScore: 4)
American J. of Surgery     Hybrid Journal   (Followers: 37, SJR: 1.141, CiteScore: 2)
American J. of the Medical Sciences     Hybrid Journal   (Followers: 12, SJR: 0.767, CiteScore: 1)
Ampersand : An Intl. J. of General and Applied Linguistics     Open Access   (Followers: 6)
Anaerobe     Hybrid Journal   (Followers: 4, SJR: 1.144, CiteScore: 3)
Anaesthesia & Intensive Care Medicine     Full-text available via subscription   (Followers: 63, SJR: 0.138, CiteScore: 0)
Anaesthesia Critical Care & Pain Medicine     Full-text available via subscription   (Followers: 15, SJR: 0.411, CiteScore: 1)
Anales de Cirugia Vascular     Full-text available via subscription  
Anales de Pediatría     Full-text available via subscription   (Followers: 3, SJR: 0.277, CiteScore: 0)
Anales de Pediatría (English Edition)     Full-text available via subscription  
Anales de Pediatría Continuada     Full-text available via subscription  
Analytic Methods in Accident Research     Hybrid Journal   (Followers: 5, SJR: 4.849, CiteScore: 10)
Analytica Chimica Acta     Hybrid Journal   (Followers: 39, SJR: 1.512, CiteScore: 5)
Analytical Biochemistry     Hybrid Journal   (Followers: 174, SJR: 0.633, CiteScore: 2)
Analytical Chemistry Research     Open Access   (Followers: 10, SJR: 0.411, CiteScore: 2)
Analytical Spectroscopy Library     Full-text available via subscription   (Followers: 11)
Anesthésie & Réanimation     Full-text available via subscription   (Followers: 2)
Anesthesiology Clinics     Full-text available via subscription   (Followers: 23, SJR: 0.683, CiteScore: 2)
Angiología     Full-text available via subscription   (SJR: 0.121, CiteScore: 0)
Angiologia e Cirurgia Vascular     Open Access   (Followers: 1, SJR: 0.111, CiteScore: 0)

        1 2 3 4 5 6 7 8 | Last   [Sort by number of followers]   [Restore default list]

Journal Cover
American Journal of Medicine
Number of Followers: 43  
 
  Hybrid Journal Hybrid journal (It can contain Open Access articles)
ISSN (Print) 0002-9343 - ISSN (Online) 1555-7162
Published by Elsevier Homepage  [3163 journals]
  • The Reply
    • Abstract: Publication date: Available online 20 June 2018
      Source:The American Journal of Medicine
      Author(s): Joseph S. Alpert


      PubDate: 2018-06-21T00:43:31Z
       
  • Lesson learned through a case of pneumococcal meningitis: sometimes doing
           less is more harmful.
    • Abstract: Publication date: Available online 19 June 2018
      Source:The American Journal of Medicine
      Author(s): Ashish Verma, MuhammadHassaan Shahid, Laura Youngblood


      PubDate: 2018-06-21T00:43:31Z
       
  • The Reply
    • Abstract: Publication date: Available online 19 June 2018
      Source:The American Journal of Medicine
      Author(s): Larry A. Weinrauch, John A. D'Elia, Matthew R. Weir, Suphamai Bunnapradist, Peter V. Finn, Jiankang Liu, Brian Claggett, Anthony P. Monaco


      PubDate: 2018-06-21T00:43:31Z
       
  • Strongyloides Hyperinfection
    • Abstract: Publication date: Available online 19 June 2018
      Source:The American Journal of Medicine
      Author(s): Rhonda Dillon, David J. Riedel


      PubDate: 2018-06-21T00:43:31Z
       
  • Pneumaturia and nephrotic syndrome caused by a hidden pelvic malignancy
    • Abstract: Publication date: Available online 18 June 2018
      Source:The American Journal of Medicine
      Author(s): Weijia Li, Barton Sanders, Ashita Tolwani


      PubDate: 2018-06-21T00:43:31Z
       
  • Prostate abscesses and Staphylococcus aureus bacteremia
    • Abstract: Publication date: Available online 18 June 2018
      Source:The American Journal of Medicine
      Author(s): Ami Schattner, Talia Finn, Yair Glick, Ina Dubin


      PubDate: 2018-06-21T00:43:31Z
       
  • Medical Axioms: The Pithy Little Sayings That Reflect Deeper Knowledge
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Joseph S. Alpert


      PubDate: 2018-06-18T00:38:33Z
       
  • Learning to De-Adopt Ineffective Healthcare Practices
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Kevin Selby, Geoffrey D. Barnes


      PubDate: 2018-06-18T00:38:33Z
       
  • Returning to (Electronic) Health Records That Guide and Teach
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Shuai Xu, Arthur Papier


      PubDate: 2018-06-18T00:38:33Z
       
  • Will Cardio-Virology Be the Next Cardio-Oncology'
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Stephen A. Geraci


      PubDate: 2018-06-18T00:38:33Z
       
  • Geographic Variability in Liver Disease-Related Mortality Rates in the
           United States
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Archita P. Desai, Prashanthinie Mohan, Anne M. Roubal, Ricki Bettencourt, Rohit Loomba
      Purpose Liver disease is an important cause of morbidity and mortality in the United States. Geographic variations in the burden of chronic liver disease may have significant impact on public health policies but have not been explored at the national level. The objective of this study is to examine interstate variability in liver disease mortality in the United States. Methods We compared liver disease mortality from the 2010 National Vital Statistics Report on a state level. States in each quartile of liver disease mortality were compared with regard to viral hepatitis death rates, alcohol consumption, obesity, ethnic and racial composition, and household income. Race, ethnicity, and median household income data were derived from the 2010 US Census. Alcohol consumption and obesity data were obtained from the 2010 Behavioral Risk Factor Surveillance System Survey. Results and Conclusion We found significant interstate variability in liver disease mortality, ranging from 6.4 to 17.0 per 100,000. The South and the West carry some of the highest rates of liver disease mortality. In addition to viral hepatitis death rates, there is a strong correlation between higher percentage of Hispanic population and a state's liver disease mortality rate (r = 0.538, P < .001). Lower household income (r = 0.405, P = .003) was also associated with the higher liver disease mortality. While there was a trend between higher obesity rates and higher liver disease mortality, the correlation was not strong and there was no clear association between alcohol consumption and liver disease mortality rates.

      PubDate: 2018-06-18T00:38:33Z
       
  • A Review of Women's Neurology
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Mary Angela O'Neal
      Concern about what is best practice when caring for women with neurologic disease is a common clinical scenario. Therefore, knowledge about women's health issues and their intersection with neurologic disorders is imperative. This review will discuss the appropriate gender-based considerations in epilepsy, multiple sclerosis, migraine, autoimmune disease, sleep disorders, stroke, and paraneoplastic disorders.

      PubDate: 2018-06-18T00:38:33Z
       
  • Management of Common Benign Anorectal Disease: What All Physicians Need to
           Know
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): David Parés, Herand Abcarian
      Benign anorectal conditions produce anal pain, rectal bleeding, or discharge from the perianal region, which are highly prevalent symptoms in the general population. Hemorrhoidal disease, anal fissure, perianal abscess, proctalgia syndromes, and pruritus anii are the most common clinical disorders. Well-trained physicians, irrespective of their specialty, can treat most of these disorders and refer them to a specialist in proctology only when necessary. The aim of this review is to provide a practical guide to the management of benign anorectal disorders in terms of their initial management and the criteria for specialist referral.

      PubDate: 2018-06-18T00:38:33Z
       
  • New Injectable Agents for the Treatment of Type 2 Diabetes Part 1 –
           Injectable Insulins
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Christa M. George, AhYoung Byun, Amanda Howard-Thompson
      The United States Food and Drug Administration has recently approved several new insulin products and new formulations of existing insulin products. These new products may provide advantages over older products, such as a lower risk of nocturnal hypoglycemia and ease of dosing; however, they are costly. The first of 2 articles in a series, this review will describe the potential advantages and disadvantages of these new insulin products.

      PubDate: 2018-06-18T00:38:33Z
       
  • Cannabinoids in Patients with Nausea and Vomiting Associated with
           Malignancy and Its Treatments
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Jose M. Garcia, Tatyana A. Shamliyan


      PubDate: 2018-06-18T00:38:33Z
       
  • Eliminating In-Hospital Fecal Occult Blood Testing: Our Experience with
           Disinvestment
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Arjun Gupta, Zhouwen Tang, Deepak Agrawal


      PubDate: 2018-06-18T00:38:33Z
       
  • A Congenital Culprit: Anomalous Origin of the Left Coronary Artery from
           the Pulmonary Artery
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Pooja Prasad, Benjamin R. Stripe, Ezra A. Amsterdam, Gagan D. Singh


      PubDate: 2018-06-18T00:38:33Z
       
  • A Binge and a Breach: Cardiac Tamponade Caused by Haemophilus influenzae
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Anthony J. Kanelidis, Drew Oehler, Cassandra L. Oehler, Jonathan Rosenberg, Jonathan D. Paul


      PubDate: 2018-06-18T00:38:33Z
       
  • No Ordinary Back Pain: Malignant Spinal Cord Compression
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Shing Fung Lee, Frank Chi Sing Wong, Stewart Yuk Tung


      PubDate: 2018-06-18T00:38:33Z
       
  • Gradually Transformed: Parry–Romberg Syndrome
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Carlos Felipe Matute, Felipe Jose Matute, Daniel Cardona, Daniel G. Federman


      PubDate: 2018-06-18T00:38:33Z
       
  • Rivaroxaban Versus Warfarin and Risk of Post-Thrombotic Syndrome Among
           Patients with Venous Thromboembolism
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Mette Søgaard, Peter Brønnum Nielsen, Flemming Skjøth, Jette Nordstrøm Kjældgaard, Craig I. Coleman, Torben Bjerregaard Larsen
      Background The effectiveness of rivaroxaban to reduce post-thrombotic syndrome in patients with venous thromboembolism is largely unknown. We compared rates of post-thrombotic syndrome in patients given rivaroxaban versus warfarin in a cohort of patients with incident venous thromboembolism receiving routine clinical care. Methods We linked Danish nationwide registries to identify all patients with incident venous thromboembolism who were new users of rivaroxaban or warfarin and compared rates of post-thrombotic syndrome using an inverse probability of treatment-weighting approach to account for baseline confounding. Results We identified 19,957 oral anticoagulation–naive patients with incident venous thromboembolism treated with warfarin or rivaroxaban (mean age, 64 years; 48% were female, 45.5% had pulmonary embolism). The propensity-weighted rate of post-thrombotic syndrome at 3 years follow-up was 0.53 incidents per 100 person-years with rivaroxaban versus 0.55 per 100 person-years with warfarin, yielding a hazard rate of 0.88 (95% confidence interval, 0.66-1.17). This association remained consistent across types of venous thromboembolism (deep venous thrombosis vs pulmonary embolism, and provoked vs unprovoked venous thromboembolism) and when censoring patients with recurrent venous thromboembolism. Conclusions In this clinical practice setting, rivaroxaban was associated with lower but statistically nonsignificant rates of post-thrombotic syndrome, which did not appear to be mediated only by an effect on recurrent venous thromboembolism.

      PubDate: 2018-06-18T00:38:33Z
       
  • Thiazolidinediones and Risk of Atrial Fibrillation Among Patients with
           Diabetes and Coronary Disease
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Jannik Langtved Pallisgaard, Maria Mori Brooks, Bernard R. Chaitman, Derek B. Boothroyd, Marco Perez, Mark A. Hlatky
      Background We sought to determine whether insulin-sensitizing therapy (thiazolidinediones or metformin) decreased the risk of developing atrial fibrillation compared with insulin-providing therapy (insulin, sulfonylurea, or a meglitinide). Thiazolidinediones are insulin sensitizers that also decrease the inflammatory response. Because inflammation is a risk factor for atrial fibrillation, we hypothesized that treating diabetes with thiazolidinediones might decrease the risk of developing atrial fibrillation. Methods The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial enrolled patients with type 2 diabetes and documented coronary artery disease. All patients were randomized to insulin-sensitizing therapy or insulin-providing therapy. Results A total of 2319 patients entered the study, with 1160 assigned to the insulin-sensitization strategy and 1159 assigned to the insulin-provision strategy. Over a median follow-up of 4.2 years, 90 patients (3.9%) developed new-onset atrial fibrillation. In the intention-to-treat analysis, the incidence of atrial fibrillation was 8.7 per 1000 person-years in patients assigned to insulin sensitization compared with 9.5 in patients assigned to insulin provision with a hazard ratio (HR) of 0.91 (95% confidence interval [CI], 0.60-1.38, P = .66). In a time-varying exposure analysis, the incidence rate per 1000 person-years was 7.2 while exposed to thiazolidinediones and 9.7 while not exposed to thiazolidinediones with an adjusted HR of 0.80 (95% CI, 0.33-1.94, P = .62). In a subset of patients matched on propensity to receive a thiazolidinediones, the HR was 0.75 (95% CI, 0.43-1.30, P = .30). Conclusions We did not find a significant reduction of atrial fibrillation incidence with use of thiazolidinediones.

      PubDate: 2018-06-18T00:38:33Z
       
  • Alogliptin in Patients with Type 2 Diabetes Receiving Metformin and
           Sulfonylurea Therapies in the EXAMINE Trial
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): William B. White, Simon R. Heller, Christopher P. Cannon, Heena Howitt, Kamlesh Khunti, Richard M. Bergenstal
      Background We evaluated the antihyperglycemic efficacy and safety of adding the dipeptidyl dipeptidase-4 inhibitor alogliptin to metformin and sulphonylurea in the treatment of type 2 diabetes in the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care Trial. Methods Patients with type 2 diabetes and recent acute coronary syndrome were randomized to alogliptin or placebo and standard of care. Participants were followed for up to 40 (median 18) months. In a subgroup taking metformin and sulphonylurea at baseline, we evaluated change from baseline in glycated hemoglobin (HbA1c), adverse events, cardiovascular outcomes, laboratory data, and other safety parameters. Results There were 1398 patients receiving baseline dual therapy (metformin and sulphonylurea only) randomized to alogliptin (N = 693) or placebo (N = 705); 550 patients receiving alogliptin and 505 patients receiving placebo completed the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care without addition of other antihyperglycemic therapies (P = .008). Changes from baseline to last visit in HbA1c were −0.4% on alogliptin and +0.1% on placebo (P < .001) in all those with baseline dual therapy and −0.4% for alogliptin and +0.2% for placebo (P < .001) in those without additional therapies. Reported rates of hypoglycemia were 8.8% for alogliptin and 6.7% for placebo (P = .16). Cardiovascular death and all-cause mortality rates were lower in those receiving alogliptin compared with those receiving placebo (hazard ratio, 0.49; 95% confidence interval, 0.28-0.84 and hazard ratio, 0.61; 95% confidence interval, 0.38-0.96, respectively). Conclusions Addition of the dipeptidyl peptidase-4 inhibitor alogliptin to dual therapy with metformin plus sulfonylurea significantly reduced HbA1c and was well tolerated. Lower mortality rates were seen in patients treated with alogliptin in this subgroup.

      PubDate: 2018-06-18T00:38:33Z
       
  • Effect of Spironolactone on Myocardial Fibrosis and Other Clinical
           Variables in Patients with Hypertrophic Cardiomyopathy
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Martin S. Maron, Raymond H. Chan, Navin K. Kapur, Iris Z. Jaffe, Adam P. McGraw, Raj Kerur, Barry J. Maron, James E. Udelson
      Background Myocardial fibrosis has proved to be an important marker and determinant in the pathogenesis of hypertrophic cardiomyopathy. In particular, scar formation, if substantial, can promote ventricular tachyarrhythmias or progressive heart failure in the absence of left ventricular outflow obstruction. Therefore, an intervention to mitigate myocardial fibrosis would be potentially advantageous to hypertrophic cardiomyopathy patients. Methods Eligible hypertrophic cardiomyopathy patients were randomized 1:1 in a prospective double-blind fashion to spironolactone 50 mg or placebo to be taken over a 12-month period. The primary endpoint was the effect of mineralocorticoid receptor blockade on serum markers of collagen synthesis and degradation. A number of other functional and morphologic variables and biomarkers comprised secondary exploratory measures. Results Fifty-three hypertrophic cardiomyopathypatients (41 ± 13 years old; 72% men) were randomized; demographic and clinical variable were well matched at baseline. Absolute change between baseline and 12 months did not differ between hypertrophic cardiomyopathy patients treated with spironolactone and those receiving placebo with respect to serum markers of collagen synthesis or degradation, fibrosis by late gadolinium enhancement on cardiac magnetic resonance imaging, or other clinical variables, including objective measure of functional capacity (peak VO2), New York Heart Association functional class, left ventricular wall thickness, mass and volume, and left atrial size, as well as assessment of diastolic function (P = .4-1.0). Conclusions These findings do not support the use of spironolactone in hypertrophic cardiomyopathy to improve left ventricular remodeling by mitigating myocardial fibrosis or altering clinical course.

      PubDate: 2018-06-18T00:38:33Z
       
  • Is the Popularity of Dipeptidyl-Peptidase-4 Inhibitors Justified'
           Insights From Mechanistic Studies and Clinical Trials
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Milton Packer


      PubDate: 2018-06-18T00:38:33Z
       
  • Vena Cava Compression Syndrome in Obesity is Reversed by Bariatric Surgery
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Yvonne Bewarder, Ingrid Kindermann, Michael Böhm


      PubDate: 2018-06-18T00:38:33Z
       
  • From Mechanical to Chemical: A Case of Diabetes Insipidus Induced by
           Concussive Brain Injury
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Muhammad Hassaan Shahid, Ashish Verma, Laura Youngblood


      PubDate: 2018-06-18T00:38:33Z
       
  • Skin and Nasal Involvement: Look for Sarcoidosis!
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Thomas Radulesco, Pierre-André Jarrot, Raphael Cauchois, Nicolas Macagno, Gilles Kaplanski, Patrick Dessi, Justin Michel


      PubDate: 2018-06-18T00:38:33Z
       
  • Sepsis-Associated Encephalopathy with Multiple Microbleeds in Cerebral
           White Matter
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Akihiro Shindo, Kei Suzuki, Yoshiaki Iwashita, Hidekazu Tomimoto


      PubDate: 2018-06-18T00:38:33Z
       
  • Hypertriglyceridemia-Induced Acute Pancreatitis with Normal Pancreatic
           Enzymes
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Sho Kitagawa, Koya Sawai


      PubDate: 2018-06-18T00:38:33Z
       
  • Polymyalgia Rheumatica with Normal Inflammatory Markers
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Shingo Suzuki, Yuta Hirose, Eriko Takeda, Masatomi Ikusaka


      PubDate: 2018-06-18T00:38:33Z
       
  • Importance of Genetic Testing in the Diagnosis of Transthyretin Cardiac
           Amyloidosis
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Jessica R. Golbus, Joanna M. Wells, Michael G. Dickinson, Scott L. Hummel


      PubDate: 2018-06-18T00:38:33Z
       
  • Raccoon Eye Appearance: Amyloidosis
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Hiroki Matsuura, Yoshiaki Anzai, Naoki Kuninaga, Takeshi Maeda


      PubDate: 2018-06-18T00:38:33Z
       
  • How to Attract More Physicians Into Primary Care
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Edward Volpintesta


      PubDate: 2018-06-18T00:38:33Z
       
  • The Reply
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): James E. Dalen


      PubDate: 2018-06-18T00:38:33Z
       
  • Dubious Benefit of Inferior Vena Cava Filters
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Paul A. Bergl


      PubDate: 2018-06-18T00:38:33Z
       
  • The Reply
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Paul D. Stein, Fadi Matta, Mary J. Hughes


      PubDate: 2018-06-18T00:38:33Z
       
  • Comments on Chronic Kidney Disease, Basal Insulin Glargine, and Health
           Outcomes in People with Dysglycemia: The Origin Study
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Saeid Safiri


      PubDate: 2018-06-18T00:38:33Z
       
  • The Reply
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Vasilios Papademetriou


      PubDate: 2018-06-18T00:38:33Z
       
  • Bilateral Tarsal Tunnel Syndrome
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Junpei Komagamine


      PubDate: 2018-06-18T00:38:33Z
       
  • Serum Cardiac Troponin T Levels in Asymptomatic Elderly Nursing Home
           Residents
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Amir Orlev, Robert Klempfner, David Rott
      Background The definition of myocardial infarction relies on elevated troponin levels. However, elevated levels of high sensitive cardiac troponin (hs-cTnT) assays have been reported in elderly patients without acute myocardial infarction. We sought to determine whether elevated hs-cTnT levels have a prognostic value in stable elderly subjects without any acute illness. Methods The study cohort included residents of a nursing home who were asymptomatic without any acute medical problem. Serum hs-cTnT levels were measured, and participants were divided into high and low hs-cTnT groups. We measured hs-cTnT levels of young healthy volunteers as well and compared them with hs-cTnT levels of those nursing home residents. Results Fifty-seven nursing home residents and 14 young volunteers were included in the study. The average age of nursing home residents was 83 ± 14 years, compared with 37 ± 3 years of the volunteers. Levels of hs-cTnT were significantly higher in the elderly compared with the volunteers (0.02 ± 0.016 ng/mL vs 0.005 ± 0.0003 ng/mL; P < .001); accordingly, we chose a cutoff of 0.02 ng/mL hs-cTnT and divided the 57 patients into 2 subgroups for further evaluation. After adjustment for age, gender, and glomerular filtration rate, the hs-cTnT was still an independent predictor of 1-year mortality (relative risk 2.04 [95% conficence interval, 2.009-29.45], P = .003). Conclusions Mild elevations of hs-cTnT levels are common in elderly patients, and hs-cTnT level is an independent marker of mortality risk in this population. For patients older than 70 years, a different hs-cTnT cutoff is required (eg, higher than 0.014 ng/mL).

      PubDate: 2018-06-18T00:38:33Z
       
  • Impact of an Interdisciplinary Computational Research Section in a
           Department of Medicine: An 8-Year Perspective
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Avrum Spira, David Coleman


      PubDate: 2018-06-18T00:38:33Z
       
  • Moments of Wonder
    • Abstract: Publication date: July 2018
      Source:The American Journal of Medicine, Volume 131, Issue 7
      Author(s): Antony Rosen


      PubDate: 2018-06-18T00:38:33Z
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 54.198.86.28
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-